Bayer Guidance Is Mostly Above Barclays's Expectations, But Cash Flow Looks Light -- Market Talk

Dow Jones
03/05

1339 GMT - - Bayer reported fourth-quarter results that were generally above Barclays's forecasts while 2025 group guidance for sales also came in slightly better at the midpoint. The midpoint of the Ebitda target was marginally above the bank's expectations, though free cash flow guide was set lower than Barclays's views, it says. The U.K. bank expects the focus of the company's earnings call to include the potential impact of tariffs, particularly on crop science, and free cash flow over the next couple of years. The bank had been forecasting free cash flow of 2.6 billion euros or 2025 versus company guidance of 1.5 billion to 2.5 billion euros. Barclays has an equal weight rating and 22 euro price target on the stock. Shares rise 3.1% at 24.25 euros. (dominic.chopping@wsj.com)

 

(END) Dow Jones Newswires

March 05, 2025 08:39 ET (13:39 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10